null

SMILES: CN(C)C1CCN(C1)c1ccc(N2CCC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1

InChI Key: InChIKey=FUYKZUFXKPWSRS-FBLFFUNLSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 497408   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM497408 (US11008301, Example 81) Show SMILES CN(C)C1CCN(C1)c1ccc(N2CCC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1 |r| Show InChI InChI=1S/C24H28ClF2N5O2/c1-30(2)17-9-11-31(14-17)16-6-8-22(19(27)13-16)32-10-3-4-21(23(32)33)29-24(34)28-20-7-5-15(25)12-18(20)26/h5-8,12-13,17,21H,3-4,9-11,14H2,1-2H3,(H2,28,29,34)/t17?,21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.70E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US11008301 (2021)
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM497408 (US11008301, Example 81) Show SMILES CN(C)C1CCN(C1)c1ccc(N2CCC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1 |r| Show InChI InChI=1S/C24H28ClF2N5O2/c1-30(2)17-9-11-31(14-17)16-6-8-22(19(27)13-16)32-10-3-4-21(23(32)33)29-24(34)28-20-7-5-15(25)12-18(20)26/h5-8,12-13,17,21H,3-4,9-11,14H2,1-2H3,(H2,28,29,34)/t17?,21-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.310	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US11008301 (2021)
					More data for this Ligand-Target Pair